Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-30

Clinical Trial Update: Empagliflozin and Renal Oxygenation in Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing empagliflozin effects on renal oxygenation in healthy volunteers with nephropathy in the study context.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Nephropathy | Phase 2 | Status: COMPLETED